Skip to content
healthcare.dev
Get a free key

ERIBULIN MESYLATE

NDC 39822-2080, eribulin mesylate, injection, from XGen Pharmaceuticals DJB, Inc..

Product NDC
39822-2080
Status
Listed
Labeler
XGen Pharmaceuticals DJB, Inc.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219054
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/39822-2080 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERIBULIN MESYLATE.5 mg/mL

Pharmacologic classes

Microtubule Inhibition [PE]; Microtubule Inhibitor [EPC]

Package NDCNDC-11Package
39822-2080-1398222080011 VIAL, SINGLE-DOSE in 1 CARTON (39822-2080-1) / 2 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4d3a9ac3-10e9-cad5-e063-6394a90a461f

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=39822-2080

Use it

Look up 39822-2080 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/39822-2080 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 39822-2080. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.